IRIS-PREMIER REGISTRY

CompletedOBSERVATIONAL
Enrollment

2,006

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2021

Conditions
Coronary Artery DiseaseMyocardial IschemiaCoronary DiseaseHeart Diseases
Interventions
DEVICE

Promus PREMIER

Trial Locations (25)

Unknown

Hallym University Sacred Heart Hospital, Anyang

Soon Chun Hyang University Hospital Cheonan, Cheonan

Chungbuk National University Hospital, Cheongju-si

Gangwon National Univ. Hospital, Chuncheon

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

Yeungnam University Medical Center, Daegu

Chungnam National University Hospital, Daejeon

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

Gangneung Asan Hospital, Gangneung

Gachon University Gil Hospital, Incheon

Kwangju Christian Hospital, Kwangju

Inje University Pusan Paik Hospital, Pusan

Kosin University Hospital, Pusan

Pusan National University Hospital, Pusan

Asan Medical Hospital, Seoul

Eulji General Hospital, Seoul

Kangdong Sacred Heart Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyunghee University Medical Center, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea St. Paul's Hospital, Seoul

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

Ulsan University Hospital, Ulsan

Pusan National University Yangsan Hospital, Yangsan

Sponsors
All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Boston Scientific Korea Co. Ltd

INDUSTRY

lead

Seung-Jung Park

OTHER

NCT02060968 - IRIS-PREMIER REGISTRY | Biotech Hunter | Biotech Hunter